In late February 2021, the U.S. President ordered a 100-day review into his country’s global supply chains, expressing concerns about availability of medicines, computer chips, minerals for advanced technologies and large batteries for electric vehicles. The executive order is the jumping-off point for this episode’s wide-ranging discussion on how the pandemic – and challenges distributing PPE and vaccines – has prompted global business leaders to scrutinize their own supply chain resilience. Alan Maner, sr. business risk consultant, explains where business leaders can start.